HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Pauly, D. F. Search for Related Content PubMed Articles by Pauly, D. F.

Cardiac Function and Heart Failure

Division of Cardiovascular Medicine, University of Florida College of Medicine, Gainesville, Florida

View larger version (24K): [in a new window]   Figure 1 Distribution of Cardiac Function and Heart Failure abstract submissions by subtopic.

View larger version (22K): [in a new window]   Figure 2 Curves showing that event-free survival is better in heart failure patients whose therapy is guided by plasma brain natriuretic peptide (BNP) levels. Reprinted from Jourdain et al. (4) with permission.

View larger version (18K): [in a new window]   Figure 3 Hemodynamic parameters in post-myocardial infarction (MI) animals are best when the rats are acutely treated with a seven-day continuous infusion of high-dose brain natriuretic peptide (BNP) (cross-hatched bars), as compared to infusion with saline (empty bars) or low-dose BNP (ruled bars). The hemodynamics were measured 8 weeks after the experimental MI and 7 weeks after completion of the infusion. Adapted from Xydas et al. (5) with permission.

View larger version (17K): [in a new window]   Figure 4 Gradual rise in filling pressures as assessed by implanted hemodynamic monitoring device in patients with chronic, end-stage kidney disease on hemodialysis. Values were recorded the first, second, and third nights after hemodialysis therapy. Adapted from Linde et al. (13) with permission. PA = pulmonary arterial; RV = right ventricular.

View larger version (17K): [in a new window]   Figure 5 Survival curves for patients with good functional capacity at study entry (group 1), good functional capacity only after completing phase II cardiac rehabilitation (group 2), and poor functional capacity despite completing phase II cardiac rehabilitation (group 3). Reprinted from Pothier et al. (15) with permission.